|
AutoImmune Inc. - Company Profile Snapshot
| Company Profile: |
AutoImmune Inc. |
| Ticker: |
AIMM |
| Exchanges: |
OTC |
| 2008 Sales: |
316,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
0 |
Business Description
AutoImmune Inc.. The Company's principal activities are developing and marketing pharmaceutical products for the treatment of autoimmune and other cell-mediated inflammatory diseases. The products are based on the principles of mucosal tolerance. Mucosal tolerance utilizes the natural immune system mechanisms associated with the gut, nasal passages, lungs and other mucosally lined tissues. The Company presently focused on products for three diseases: rheumatoid arthritis, multiple sclerosis and Type 1 diabetes. It operates in the United States of America. The Company is in the development stage.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
